United States · Series C startup

Who invested in FLX Bio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$60Mraised across 1 round since 2017, from 1 source

Latest round
Series C, $60MDec 2017
Investors
5
See who backed them

The rounds

  1. Dec 2017
    Series C$60M

    Reported by VcnewsdailySEC filing: $30M sold, first sale Dec 2017

Founders and team

From the SEC filings it signed: 2 on the team.

  • Brian WongExecutive Officer, Directori
  • Rekha J. HemrajaniExecutive Officeri

On the board, as filediBeth SeidenbergDavid GoeddelLinda J. KozickWilliam J. Rieflin

Everyone who backed them

Google VenturesCorporate VC1round
The Column GroupVC firm1round
CelgeneGrowth equity1round
KPCBno record of our own yet1round
Topspinno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about FLX Bio

Who invested in FLX Bio?

FLX Bio's investors include Google Ventures, The Column Group, Celgene, KPCB and Topspin.

How much has FLX Bio raised?

FLX Bio has raised $60M across 1 round since 2017.

When did FLX Bio last raise?

FLX Bio's most recent round was a Series C of $60M in Dec 2017.

What was FLX Bio's biggest round?

Its most recent round, $60M in Dec 2017, is also its largest on record.

Who backed FLX Bio first?

FLX Bio's first round on record, in Dec 2017, was backed by Google Ventures, The Column Group and Celgene and 2 others.

What stage is FLX Bio at?

FLX Bio's latest named round is a Series C, in Dec 2017.

Where is FLX Bio based?

FLX Bio is based in the United States.

Companies like FLX Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.